LATISSE® is the first FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller, and darker.
LATISSE® was created by Allergan. In 2001, Allergan developed a medicated eye drop to treat elevated intraocular pressure. Many patients using this medication also began to grow longer, fuller and darker lashes as a side effect. This led Allergan to study the medication's active ingredient, bimatoprost, specifically for growing lashes. After a clinical trial, LATISSE® was approved by the FDA in December of 2008.
Latisse® 5 ML
Latisse® 3 ML
Showing items 1-2 of 2.